Roche delays $4.3B Spark buyout — again — as FTC review drags on
The Roche/Spark deal is still happening. On time. It’s just going to take a little longer.
So says the Swiss giant, which has extended its tender offer for a second time. Withdrawing and refiling the Premerger Notification and Report Form gives the FTC more time to complete its regulatory review — a routine practice that was also cited as reason for delay three weeks ago.
“This was done in agreement with Spark and the relevant FTC stakeholders and is not unusual in a transaction of this type,” a spokesperson said in an email.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
